Norio Oshida

Title: Norio Oshida: Innovator in Cyclic Depsipeptides

Introduction

Norio Oshida is a prominent inventor based in Saitama-ken, Japan. He has made significant contributions to the field of peptide synthesis, holding a total of 14 patents. His work focuses on developing innovative compounds that have therapeutic applications.

Latest Patents

Oshida's latest patents include cyclic depsipeptides and drugs containing these compounds as active ingredients. These cyclic depsipeptides are characterized by a specific formula where R represents a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15 carbon atoms. The compounds are designed to promote the production of apolipoprotein E, serve as therapeutic agents for neurological damages and dementia, inhibit the production of apolipoprotein B, promote the production of apolipoprotein A1, and act as therapeutic agents for hyperlipemia. Additionally, he has developed depsipeptides containing N-substituted glycine residues, which further expand the potential applications of his research.

Career Highlights

Throughout his career, Norio Oshida has worked with notable companies such as Nisshin Flour Milling Co., Ltd. and Nisshin Seifun Group Inc. His experience in these organizations has contributed to his expertise in the field of peptide synthesis and drug development.

Collaborations

Oshida has collaborated with esteemed colleagues, including Makoto Yanai and Shigeru Hiramoto. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

Norio Oshida's contributions to the field of cyclic depsipeptides and his extensive patent portfolio highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic agents that can address significant health challenges.